Drawing for ATLAS

USPTO serial 99023083

ATLAS

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
GAYNOR, BARBARA ANNE
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with ATLAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael R Gilman

Michael R Gilman Kaplan Breyer Schwarz LLP317 George StreetSuite 320New Brunswick, NJ 08901

Goods and services

ClassDescriptionStatusFirst use
009Downloadable medical software for processing and displaying an interactive 3D navigation guide for contemporaneous, real-time use with visual 3D overlays of a patient's cardiac conduction system during invasive and minimally invasive medical procedures; Downloadable medical software for medical imaging equipment, namely, for processing and displaying an interactive 3D navigation guide for contemporaneous, real-time use with visual 3D overlays generated using CT imaging equipment; Downloadable medical software for processing and displaying contemporaneous, real-time fluoroscopic data integrated with a patient's cardiac conduction systemACTIVE—
042Providing temporary use of on-line non-downloadable software for processing and displaying an interactive 3D navigation guide for contemporaneous, real-time use with visual 3D overlays of a patient's cardiac conduction system during invasive and minimally invasive medical procedures in the medical field; Providing temporary use of on-line non-downloadable software for medical imaging equipment, namely, for processing and displaying an interactive 3D navigation guide for contemporaneous, real-time use with visual 3D overlays generated using CT imaging equipment; Providing temporary use of on-line non-downloadable software for processing and displaying contemporaneous, real-time fluoroscopic data integrated with a patient's cardiac conduction system for use in the medical fieldACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 25, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 21, 2026EX1GSOU EXTENSION 1 GRANTED—
Oct 21, 2026EXT1SOU EXTENSION 1 FILED—
Oct 21, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 20, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 25, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 25, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 19, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 31, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 23, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 23, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 22, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 22, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Jul 22, 2025CNSLSUSPENSION LETTER WRITTEN—
Jul 21, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 21, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 21, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 10, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2025DOCKASSIGNED TO EXAMINER—
Jul 1, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 30, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 30, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance